Literature DB >> 12837042

Pigment epithelium-derived factor Met72Thr polymorphism in patients with diabetic microangiopathy.

S Yamagishi1, S Amano, Y Inagaki, T Okamoto, Y Koda, M Soejima, H Kimura.   

Abstract

Pigment epithelium-derived factor (PEDF) has recently been shown to be the most potent inhibitor of angiogenesis in the mammalian eye. We, along with others, have very recently found that loss of PEDF is involved in the development and progression of diabetic retinopathy. However, there are no studies on the allelic effects of PEDF gene polymorphism in diabetic retinopathy. In this study, we investigated whether a functional amino acid change, a methionine to threonine polymorphism (Met72Thr polymorphism) of the PEDF gene, is associated with microangiopathy in 143 patients with diabetes. We found that there were no significant associations between PEDF Met72Thr gene polymorphism and diabetic microangiopathy. These observations suggest that these genetic variants might not be involved in the mechanism of diabetic microangiopathy in patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12837042

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  3 in total

Review 1.  Association of PEDF polymorphisms with age-related macular degeneration and polypoidal choroidal vasculopathy: a systematic review and meta-analysis.

Authors:  Li Ma; Shu Min Tang; Shi Song Rong; Haoyu Chen; Alvin L Young; Govindasamy Kumaramanickavel; Chi Pui Pang; Li Jia Chen
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

Review 2.  Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to Treatment.

Authors:  Rajya L Gurung; Liesel M FitzGerald; Bennet J McComish; Nitin Verma; Kathryn P Burdon
Journal:  J Diabetes Res       Date:  2020-11-12       Impact factor: 4.011

3.  Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration.

Authors:  Dietmar Mattes; Anton Haas; Wilfried Renner; Iris Steinbrugger; Yosuf El-Shabrawi; Andreas Wedrich; Christoph Werner; Otto Schmut; Martin Weger
Journal:  Mol Vis       Date:  2009-02-16       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.